Graham Capital Management’s Pfizer PFE Stock Holding History

Graham Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-82,339	Closed	-$2.09M	–	1539
2025 Q1	$2.09M	Buy	+82,339	New	+$2.15M	0.04%	314
2024 Q4	–	Sell	-203,363	Closed	-$5.89M	–	1422
2024 Q3	$5.89M	Sell	203,363 -214	-0.1%	-$6.24K	0.1%	111
2024 Q2	$5.7M	Buy	203,577 +176,563	+654%	+$4.86M	0.12%	98
2024 Q1	$750K	Sell	27,014 -6,802	-20%	-$189K	0.01%	502
2023 Q4	$974K	Buy	+33,816	New	+$1.02M	0.02%	398
2023 Q3	–	Sell	-64,056	Closed	-$2.35M	–	1226
2023 Q2	$2.35M	Buy	+64,056	New	+$2.49M	0.07%	190
2022 Q4	–	Sell	-21,901	Closed	-$958K	–	1272
2022 Q3	$958K	Sell	21,901 -36,104	-62%	-$1.75M	0.04%	506
2022 Q2	$3.04M	Buy	+58,005	New	+$2.96M	0.12%	111
2015 Q4	–	Sell	-28,985	Closed	-$864K	–	80
2015 Q3	$864K	Buy	+28,985	New	+$929K	0.1%	94

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Graham Capital Management's PFE Position: Q2 2025 in Review

Graham Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 82,339 shares — an estimated $2.09M sold.

Graham Capital Management first reported a position in PFE in Q3 2015 and held it in 9 quarters. The position peaked at $5.89M in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Graham Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Graham Capital Management sold 82,339 Pfizer shares in Q2 2025, an estimated $2.09M.
Graham Capital Management first reported a position in Pfizer in Q3 2015 and held it in 9 quarters.
Graham Capital Management's Pfizer position peaked at $5.89M in Q3 2024.
2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.